Artificial Heart Market Sales Revenue, Size, Key Updates and Forecast to 2028

The artificial heart market is projected to grow from US$ 1.98 billion in 2021 to US$ 4.99 billion by 2028; it is expected to grow at a CAGR of 15.5% from 2022 to 2028.

Artificial hearts, powered by either compressed air or electricity, help patients with total heart failure live normal lives past their life expectancy timeline or help them survive until their transplant date. These products are deployed to either completely replace the heart or replace only the ventricles. The device is surgically implanted in the chest to assist a deteriorating heart with its functions. An artificial heart may be used temporarily and is removed once the heart starts functioning normally. In cases where the damage is severe, the biological heart is completely replaced with an artificial heart.

Download PDF Sample Copy at:
https://www.theinsightpartners.com/sample/TIPHE100001412/?utm_source=OpenPR&utm_medium=10376

MARKET DYNAMICS

A surge in the incidence of cardiac disorders and an increase in the geriatric population drive the artificial heart market. Improper lifestyles, leading to deteriorating cardiac conditions, are likely to create growth opportunities for the manufacturers of artificial hearts. However, the high cost of artificial heart valves and rigorously regulated treatment facilities are the factors hampering the growth of the market.

MARKET SCOPE

"Global Artificial Heart Market Analysis to 2028" report aims to provide an overview of the market with detailed segmentation based on the system. The report provides key market statistics based on the performances of the leading players. It also describes key trends and opportunities in the market.

REGIONAL ANALYSIS

The artificial heart market is segmented into five major regions-North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report covers the analysis and forecast of 18 countries worldwide, along with trends and opportunities prevailing in every region.

North America dominated the artificial heart market with ~49% share in 2021. The market growth in the region is majorly attributed to a high cardiovascular and neurological disease prevalence, and a large geriatric population. Key market players in the region use good-quality materials and other accessories for the manufacturing of artificial heart valves. In July 2022, China's National Medical Products Administration issued marketing approval for the artificial heart of a domestic made for severe heart failure cases. The artificial heart is an implantable ferrofluids-driven left ventricular assist device. In February 2020, Abbott received Breakthrough Device designation from the US Food and Drug Administration (FDA) for its Fully Implantable Left Ventricular Assist System (FILVAS). The following figure depicts the revenue growth trend in the global artificial heart market.

IMPACT OF COVID-19 PANDEMIC

The emergence of COVID-19 compelled healthcare providers to deprioritize or postpone therapeutic procedures, which adversely affected the sales of cardiovascular devices, such as artificial hearts, especially in 2020. The study "The Impact of the COVID-19 Pandemic on Waiting Times for Elective Surgery Patients: A Multicenter Study," published in July 2021, stated that the incidence of elective procedures decreased rapidly after the onset of the first COVID-19 wave, in March 2020; nonetheless, there has been a recovery in May and June, after which the surgery incidence was 22% higher than that in the reference years. The pandemic and consequent social restrictions, and labor force shortage hampered the manufacturing of heart valves and related materials.

MARKET PLAYERS

SynCardia Systems
LLC, BiVACOR Inc.
CARMAT
Cleveland Heart, Inc.
ABIOMED
ON-X LIFE TECHNOLOGIES INC.
Abbott
Cirtec
Thoratec Corporation
MyLVAD

Buy Report at:
https://www.theinsightpartners.com/buy/TIPHE100001412/?utm_source=OpenPR&utm_medium=10376

Contact us:

If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About The Insight Partners:

The Insight Partners is a one top industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Manufacturing and Construction, Technology, Chemicals and Materials.
We offer our clients multiple ways to customize research as per their specific needs and budget.

This release was published on openPR.